Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
BPS Bioscience Inc Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line, 2 vials
Supplier: BPS Bioscience Inc 79853
The Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line is a specialized research tool designed for evaluating anti-CD19 CAR constructs and lentiviruses. This double stable Jurkat cell line integrates a robust CAR design with an NFAT-dependent luciferase reporter, enabling efficient measurement of CAR activation in co-culture with CD19-expressing target cells. It streamlines the validation of CAR T-cell development workflows through its comprehensive design and validated performance.
- Comprehensive CAR design with anti-CD19 scFv linked to a 3rd generation CAR
- NFAT-luciferase reporter system for quantitative CAR activation assessment
- Validated for CAR expression using FACS and luciferase activation
- Ideal for primary screening and functional validation of CAR constructs
- Screened for mycoplasma absence
- Stored at -80°C
- BSL-2 biosafety level
- Research use only
- Supplied in 2 vials
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?